Skin Microbiome

Modulation of microorganisms that reside on the skin.

LUX TAKE:

As the gap between science and product development closes, we expect that the skin microbiome space will have a profound impact on future formulations in the beauty and personal care market. Product development will be a multiyear process in the skin microbiome space, and companies that choose to "wait and see" will find themselves behind their peers within two years. Partnerships through the ...

Lux Take last updated on June 05, 2020
Data last updated on March 25, 2021

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent skin microbiome developments.

News Commentaries

L'Oréal partners with bacteriophage company Micreos for skin microbiome applications (November 12, 2020)

Bayer expands its collaboration with skin microbiome startup Azitra by leading its $17 million Series B round (October 26, 2020)

New Lux Content

Picture-perfect: Predictions for the cosmetics industry in 2021 (March 12, 2021)

Accelerating Materials Innovation: Key Developments and Predictions for 2021 (January 26, 2021)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	Phagelux, Micreos, Dermala, Naked Biome, Faye Face, AOBiome, Yun Probiotherapy, Mother Dirt, Azitra, DermBiont

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978